SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 98 filers reported holding SERES THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -50.0% | 501 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | -33.3% | 501 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 501 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.8% | 501 | +59.6% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 314 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 314 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 314 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 314 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 314 | +82.6% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | -69.2% | 172 | -61.3% | 0.00% | – |
| Q3 2020 | $13,000 | +550.0% | 445 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 445 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 445 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 445 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 445 | +98.7% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 224 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 224 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 224 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 224 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 224 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |